Skip to main content

Afinitor Everolimus Copay Assistance Program

Novartis

OpenVerified·Apr 24, 2026

This grant is a copay assistance program for patients prescribed Afinitor (everolimus) for cancer or tuberous sclerosis complex (TSC) treatment. It helps commercially insured patients access manufacturer copay cards and coordinates patient assistance programs for Medicare, Medicaid, and uninsured patients through foundations like the Novartis Patient Assistance Foundation. The program aims to reduce or eliminate out-of-pocket medication costs, with QuickRx providing free support services including enrollment, insurance coordination, and home delivery.

Covers
financial assistance
Enrollment cycle
rolling

Apply

Application goes directly to Novartis. RxCopays does not receive compensation.

Go to application →

Status source

Apply for Afinitor or Zortress (Everolimus) Copay Assistance